Stroke volume and proteinuria in obesity-related glomerulopathy: potential role in pathogenesis and choice of antihypertensive regimen.
作者信息
Ogu Iheanyichukwu, Shweihat Yousef R, Shapiro Joseph I, Khitan Zeid J
机构信息
Joan C Edwards School of Medicine at Marshall University, drive Huntington, WV, USA.
出版信息
J Clin Hypertens (Greenwich). 2018 Apr;20(4):819-820. doi: 10.1111/jch.13245. Epub 2018 Feb 15.
Abstract
摘要
相似文献
1
Stroke volume and proteinuria in obesity-related glomerulopathy: potential role in pathogenesis and choice of antihypertensive regimen.肥胖相关性肾小球病中的每搏输出量与蛋白尿：在发病机制中的潜在作用及降压方案的选择
J Clin Hypertens (Greenwich). 2018 Apr;20(4):819-820. doi: 10.1111/jch.13245. Epub 2018 Feb 15.
2
[Clinical and pathological analyses of lipoprotein glomerulopathy].脂蛋白肾小球病的临床与病理分析
Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 May;35(3):442-4.
3
Proteinuria in rats induced by serum from patients with collapsing glomerulopathy.塌陷型肾小球病患者血清诱导的大鼠蛋白尿
Kidney Int. 2004 Jul;66(1):133-43. doi: 10.1111/j.1523-1755.2004.00715.x.
4
New-onset proteinuria with massive amorphous glomerular deposits.新发蛋白尿伴大量无定形肾小球沉积物。
Am J Kidney Dis. 2010 Apr;55(4):749-54. doi: 10.1053/j.ajkd.2009.05.015. Epub 2009 Jul 17.
5
Which Patients with Obesity Are at Risk for Renal Disease?哪些肥胖患者有患肾病的风险？
Nephron. 2021;145(6):595-603. doi: 10.1159/000513868. Epub 2021 Mar 5.
6
Hyperthyroidism associated with obesity-related glomerulopathy-like pathologic features.与肥胖相关的肾小球病样病理特征相关的甲状腺功能亢进症。
Intern Med. 2014;53(9):997-9. doi: 10.2169/internalmedicine.53.1814. Epub 2014 May 1.
7
Obesity-related glomerulopathy: recent advances in inflammatory mechanisms and related treatments.肥胖相关肾小球病：炎症机制及相关治疗的最新进展
J Leukoc Biol. 2024 Apr 29;115(5):819-839. doi: 10.1093/jleuko/qiae035.
8
Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.肥胖相关性肾小球病：发病机制、病理、临床特征及治疗。
Front Med. 2017 Sep;11(3):340-348. doi: 10.1007/s11684-017-0570-3. Epub 2017 Aug 8.
9
Renal failure attributable to atrophic glomerulopathy in four related rottweilers.四只相关罗威纳犬中由萎缩性肾小球病所致的肾衰竭
J Am Vet Med Assoc. 1993 Jan 1;202(1):107-9.
10
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.肥胖相关性肾小球病：临床与病理特征及发病机制。
Nat Rev Nephrol. 2016 Aug;12(8):453-71. doi: 10.1038/nrneph.2016.75. Epub 2016 Jun 6.
本文引用的文献
1
The Renal Pathology of Obesity.肥胖的肾脏病理学
Kidney Int Rep. 2017 Jan 23;2(2):251-260. doi: 10.1016/j.ekir.2017.01.007. eCollection 2017 Mar.
2
Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.肥胖相关性肾小球病：发病机制、病理、临床特征及治疗。
Front Med. 2017 Sep;11(3):340-348. doi: 10.1007/s11684-017-0570-3. Epub 2017 Aug 8.
3
How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure.抗高血压药物如何发挥作用？来自动脉血压肾脏调节研究的见解。
Front Physiol. 2016 Jul 29;7:320. doi: 10.3389/fphys.2016.00320. eCollection 2016.
4
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.肥胖相关性肾小球病：临床与病理特征及发病机制。
Nat Rev Nephrol. 2016 Aug;12(8):453-71. doi: 10.1038/nrneph.2016.75. Epub 2016 Jun 6.
5
Obesity in CKD--what should nephrologists know?慢性肾脏病患者中的肥胖症——肾科医生应该了解哪些内容？
J Am Soc Nephrol. 2013 Nov;24(11):1727-36. doi: 10.1681/ASN.2013040330. Epub 2013 Oct 10.
6
Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria.肥胖合并蛋白尿患者的近端肾小管肥大和肾小球及近端肾小管尿腔增大。
PLoS One. 2013 Sep 25;8(9):e75547. doi: 10.1371/journal.pone.0075547. eCollection 2013.
7
Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.肥胖与肾小球高滤过之间存在显著关联：一项在非洲人群中的横断面研究。
Am J Kidney Dis. 2010 Aug;56(2):303-12. doi: 10.1053/j.ajkd.2010.03.017. Epub 2010 Jun 9.
8
Simple method for evaluating cardiac output.评估心输出量的简单方法。
J La State Med Soc. 2009 Sep-Oct;161(5):287-9.
9
Predictors of new-onset decline in kidney function in a general middle-european population.一般中欧人群中新发肾功能下降的预测因素
Nephrol Dial Transplant. 2008 Apr;23(4):1265-73. doi: 10.1093/ndt/gfm790. Epub 2007 Nov 26.
10
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.血压降低及抗高血压药物类别对高血压肾病进展的影响：AASK试验结果
JAMA. 2002 Nov 20;288(19):2421-31. doi: 10.1001/jama.288.19.2421.
Zotero 插件